{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:49:16Z","timestamp":1789044556379,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2-SRA-2023-1434-S-B"],"award-info":[{"award-number":["2-SRA-2023-1434-S-B"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["GR-2018-12365982"],"award-info":[{"award-number":["GR-2018-12365982"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdiacomp.2025.109215","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:13:00Z","timestamp":1762618380000},"page":"109215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes"],"prefix":"10.1016","volume":"40","author":[{"given":"Silvia Irina","family":"Briganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Renzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Manfrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocky","family":"Strollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109215_bb0005","first-page":"311","article-title":"Estimation of annual health care costs for adults with type 1 diabetes in the United States","volume":"26","author":"Joish","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1464-5491.2007.02365.x","article-title":"In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine","volume":"25","author":"Bruttomesso","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/dia.2021.0471","article-title":"Glycemic control in relation to technology use in a single-center cohort of children with type 1 diabetes","volume":"24","author":"Sawyer","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijnurstu.2004.06.014","article-title":"Assessing the quality of life--reality or impossible dream? A discussion paper","volume":"42","author":"Holmes","year":"2005","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/a0040388","article-title":"Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice","volume":"71","author":"Gonzalez","year":"2016","journal-title":"Am Psychol"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1037\/a0040344","article-title":"Understanding diabetes and the role of psychology in its prevention and treatment","volume":"71","author":"Hunter","year":"2016","journal-title":"Am Psychol"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0040","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2337\/diacare.25.11.2100","article-title":"To pump or not to pump","volume":"25","author":"Schade","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4158\/PS-2017-0155","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology 2018 position statement on integration of insulin pumps and continuous glucose monitoring in patients with diabetes mellitus","volume":"24","author":"Grunberger","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.diabres.2010.04.010","article-title":"Is insulin pump therapy better than injection for adolescents with diabetes?","volume":"89","author":"Wu","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1464-5491.2007.02346.x","article-title":"Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections","volume":"25","author":"Life EQSG--EoQo","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15050947","article-title":"Use of diabetes treatment satisfaction questionnaire in diabetes care: importance of patient-reported outcomes","volume":"15","author":"Saisho","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0075","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2337\/dc12-0076","article-title":"Linguistic and psychometric validation of the diabetes-specific quality-of-life scale in U.K. English for adults with type 1 diabetes","volume":"36","author":"Cooke","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1590\/S0080-62342013000200011","article-title":"Quality of life in patients with diabetes mellitus before and after their participation in an educational program","volume":"47","author":"Faria","year":"2013","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/dia.2019.0152","article-title":"Satisfaction with the use of different technologies for insulin delivery and glucose monitoring among adults with long-standing type 1 diabetes and problematic hypoglycemia: 2-year follow-up in the HypoCOMPaSS randomized clinical trial","volume":"21","author":"Speight","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14944","article-title":"Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review","volume":"40","author":"Speight","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dme.14234","article-title":"Psychosocial aspects of diabetes technology","volume":"37","author":"Kubiak","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/3946553","article-title":"Understanding experiences of diabetes distress: a systematic review and thematic synthesis","volume":"2024","author":"Morales-Brown","year":"2024","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110886","article-title":"The impact of real-time sensor technology on quality of life for adults with type 1 diabetes: a Dutch national survey","volume":"203","author":"Winterdijk","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102119","article-title":"Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis","volume":"62","author":"Talbo","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003394","article-title":"Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician\u2019s perspective on its implementation","volume":"11","author":"Peter","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111596","article-title":"Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems","volume":"209","author":"Lin","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12955-014-0167-3","article-title":"Is hypoglycemia fear independently associated with health-related quality of life?","volume":"12","author":"Shi","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/19322968241276550","article-title":"Psychosocial aspects of diabetes technologies: commentary on the current status of the evidence and suggestions for future directions","volume":"19","author":"Barnard-Kelly","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/19322968231183974","article-title":"Treatment satisfaction and well-being with continuous glucose monitoring in people with type 1 diabetes: an analysis based on the GOLD randomized trial","volume":"19","author":"Pylov","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.324","article-title":"RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: systemic review and meta-analysis","volume":"5","author":"William","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0155","author":"Guardian Connect System User Guide"},{"key":"10.1016\/j.jdiacomp.2025.109215_bb0160","author":"FreeStyle Libre Performance Data Insert"}],"updated-by":[{"DOI":"10.1016\/j.jdiacomp.2025.109254","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000}},{"DOI":"10.1016\/j.jdiacomp.2025.109254","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:16:59Z","timestamp":1771532219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1056872725002685"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109215","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109215"}}